Hristo P Varbanov

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Venues

Journal of medicinal chemistry

Dalton transactions (Cambridge, England : 2003)

PloS one

University of Graz

University of Vienna (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Graz Feb 12 2018

Austria

Postdoctoral Research Scientist :: Institute of Chemistry - Inorganic Chemistry

University of Vienna Oct 18 2016 - Jan 31 2018

Austria

Senior Postdoctoral Fellow :: Faculty of Chemistry, Institute of Inorganic Chemistry

École Polytechnique Fédérale de Lausanne (EPFL) Sep 01 2014 - Sep 30 2016

Switzerland

Postdoctoral Fellow :: Institute of Chemical Sciences and Engineering

University of Sofia Dec 04 2013 - Jan 11 2014

Bulgaria

Visiting Scientist :: Faculty of Chemistry and Pharmacy

University of Vienna Feb 15 2009 - Aug 31 2013

Austria

PhD student/Researcher :: Faculty of Chemistry, Institute of Inorganic Chemistry

Education History

University of Vienna Oct 01 2009 - Apr 25 2013

Austria

PHD :: Faculty of Chemistry, Institute of Inorganic Chemistry

Medical University of Sofia Sep 15 2003 - Dec 19 2008

Bulgaria

MSC :: Faculty of Pharmacy

Publications

Patricia Grabher, Paul Kapitza, Nikolas Hörmann, Amelie Scherfler, Martin Hermann, Michael Zwerger, Hristo P Varbanov, Brigitte Kircher, Daniel Baecker, Ronald Gust
Correction to "Development of Cytotoxic GW7604-Zeise's Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor-Positive Tumor Cells". Journal of medicinal chemistry 67 (9) (2024)
Patricia Grabher, Paul Kapitza, Nikolas Hörmann, Amelie Scherfler, Martin Hermann, Michael Zwerger, Hristo P Varbanov, Brigitte Kircher, Daniel Baecker, Ronald Gust
Development of Cytotoxic GW7604-Zeise's Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor- Positive Tumor Cells. Journal of medicinal chemistry 67 (6) (2024)
Patricia Grabher, Paul Kapitza, Nikolas Hörmann, Amelie Scherfler, Martin Hermann, Michael Zwerger, Hristo P Varbanov, Brigitte Kircher, Daniel Baecker, Ronald Gust
Correction to "Development of Cytotoxic GW7604-Zeise's Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor-Positive Tumor Cells". Journal of medicinal chemistry 67 (9) (2024)
Patricia Grabher, Paul Kapitza, Nikolas Hörmann, Amelie Scherfler, Martin Hermann, Michael Zwerger, Hristo P Varbanov, Brigitte Kircher, Daniel Baecker, Ronald Gust
Development of Cytotoxic GW7604-Zeise's Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor- Positive Tumor Cells. Journal of medicinal chemistry (2024)
Patricia Grabher, Paul Kapitza, Nikolas Hörmann, Amelie Scherfler, Martin Hermann, Michael Zwerger, Hristo P Varbanov, Brigitte Kircher, Daniel Baecker, Ronald Gust
Correction to "Development of Cytotoxic GW7604-Zeise's Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor-Positive Tumor Cells". Journal of medicinal chemistry (2024)
Patricia Grabher, Paul Kapitza, Nikolas Hörmann, Amelie Scherfler, Martin Hermann, Michael Zwerger, Hristo P Varbanov, Brigitte Kircher, Daniel Baecker, Ronald Gust
Development of Cytotoxic GW7604-Zeise's Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor- Positive Tumor Cells. Journal of medicinal chemistry 67 (6) (2024)
Patricia Grabher, Paul Kapitza, Nikolas Hörmann, Amelie Scherfler, Martin Hermann, Michael Zwerger, Hristo P Varbanov, Brigitte Kircher, Daniel Baecker, Ronald Gust
Development of Cytotoxic GW7604-Zeise's Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor- Positive Tumor Cells. Journal of medicinal chemistry 67 (6) (2024)
Patricia Grabher, Paul Kapitza, Nikolas Hörmann, Amelie Scherfler, Martin Hermann, Michael Zwerger, Hristo P Varbanov, Brigitte Kircher, Daniel Baecker, Ronald Gust
Development of Cytotoxic GW7604-Zeise's Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor- Positive Tumor Cells. Journal of medicinal chemistry 67 (6) (2024)
Patricia Grabher, Paul Kapitza, Nikolas Hörmann, Amelie Scherfler, Martin Hermann, Michael Zwerger, Hristo P Varbanov, Brigitte Kircher, Daniel Baecker, Ronald Gust
Development of Cytotoxic GW7604-Zeise's Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor- Positive Tumor Cells. Journal of medicinal chemistry 67 (6) (2024)
Hristo P Varbanov, Toma Glasnov, Ferdinand Belaj, Simon Herbert, Thomas Brumby, Nadia C Mösch-Zanetti
New strategies towards advanced CT contrast agents. Development of neutral and monoanionic sulfur-bridged W(V) dimeric complexes. Dalton transactions (Cambridge, England : 2003) 51 (29) (2022)
Hristo P Varbanov, Fabien Kuttler, Damiano Banfi, Gerardo Turcatti, Paul J Dyson
Screening-based approach to discover effective platinum-based chemotherapies for cancers with poor prognosis. PloS one 14 (1) (2019)
Sarah Theiner, Marko Grabarics, Luis Galvez, Hristo P Varbanov, Nadine S Sommerfeld, Markus Galanski, Bernhard K Keppler, Gunda Koellensperger
The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs - an HPLC-ICP-MS study. Dalton transactions (Cambridge, England : 2003) 47 (15) (2018)
Hristo P Varbanov, Fabien Kuttler, Damiano Banfi, Gerardo Turcatti, Paul J Dyson
Repositioning approved drugs for the treatment of problematic cancers using a screening approach. PloS one 12 (2) (2017)

Hristo P Varbanov.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hristo P Varbanov